Overexpression and mutations of p53 in metastatic malignant melanomas

International Journal of Cancer

Volumn 67, Issue 3, 1996, Pages 313-317

  Hartmann, Arndt ^a   Blaszyk, Hagen ^a   Cunningham, Julie S ^a   Mcgovern, Renee M ^a   Schroeder, Jennifer S ^a   Helander, Steve D ^a   Pittelkow, Mark R ^a   Sommer, Steve S ^a   Kovach, John S ^a,b  

^a MAYO CLINIC   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; BASAL CELL CARCINOMA; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOMA; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MUTATION; POLYMORPHISM, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029810981     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960729)67:3<313::AID-IJC1>3.0.CO;2-U     Document Type: Article

References (34)

1. BRASH, D.E., RUDOLPH, J.A., SIMON, J.A., LIN, A., MCKENNA, G.J., BADEN, H.P., HALPERIN, A.M. and PONTÉN, J., UV-induced p53 mutations in squamous cell carcinoma. Proc. nat. Acad. Sci. (Wash.), 88, 10124-10128 (1991).
2. CASTRESANA, J.S., RUBIO, M-P., VASQUES, J.J., IDOATE, M., SOBER, A.J., SEIZINGER, B.R. and BARNHILL, R.L., Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int. J. Cancer, 55, 562-565 (1993).
3. CRISTOFOLINI, M., BOI, S., GIRLANDO, S., ZUMIANE, G., CRISTOFOLINI, P., DALLA PALMA, P., DOOLIONE, C. and BARBARESCHI, M., p53 protein expression in nevi and melanomas. Arch. Dermatol., 129, 739-743 (1993).
4. DE VRIES, E.M.G., RICKE, D.O., DE VRIES, T.N., HARTMANN, A., BLASZYK, H., SOUSSI, T., KOVACH, J.S. and SOMMER, S.S., Database of mutations in the p53 and APC tumor suppressor genes designed to facilitate molecular epidemiological analyses. Hum. Mutation, 7, 202-213 (1996).
5. DOCKHORN-DWORNICZAK, B., YANDELL, D.W., MERRITT, V., BOECKER, W. and POREMBA, C., p53 mutation in primary malignant melanoma. Proc. Amer. Assoc. Cancer Res., 34, 111 (1993) (abstract).
6. DUMAZ, N., STARY, A., SOUSSI, T., DAYA-GROSJEAN, L. and SARASIN, A., Can we predict solar ultraviolet radiation as the causal event in human tumours by analysing the mutation spectra of the p53 gene? Mutation Res., 307, 375-386 (1994).
7. FLORENES, V.A., OYJORD, T., HOLM, R., SKREDE, V.A., BORRESEN, A.L., NESLAND, J.M. and FODSTAD, O., TP53 allele loss, mutations and expression in malignant melanoma. Brit. J. Cancer, 69, 253-259 (1994).
8. GREENBLATT, M.S., BENETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
9. HALL, P.A., MCKEE, P.H., MENAGE, D.H., DOVER, R. and LANE, D.P., High levels of p53 protein UV-irradiated normal human skin. Oncogene, 8, 203-207 (1993).
10. KAMB, A., GRUIS, N., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S. III, JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
11. KASTAN, M.B., ZHAN, Q., EL-DEIRY, W., CARRIER, F., JACKS, T., WALSH, W.V., PLUNKETT, B.S., VOGELSTEIN, B. and FORNACE JR., A.J., A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell, 71, 587-597 (1992).
12. KOVACH, J.S., MCGOVERN, R.M., CASSADY, J.D., SWANSON, S.K., WOLD, L.E., VOGELSTEIN, B. and SOMMER, S.S., Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinomas. J. nat. Cancer Inst., 83, 1004-1009 (1991).
13. KRAEHN, G.M., SCHARTL, M. and PETER, R.U., Human malignant melanoma. A genetic disease? Cancer, 75, 1228-1237 (1995).
14. LANE, D.P., p53, the guardian of the genome. Nature (Lond.), 358, 15-16 (1992).
15. LASSAM, N.J., FROM, L. and KAHN, H.J., Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res., 53, 2235-2238 (1993).
16. LIU, Q. and SOMMER, S.S., Parameters affecting the sensitivities of dideoxy fingerprinting and SSCP. PCR Methods Applications, 4, 97-108 (1994).
17. LIVINGSTONE, L.R., WHITE, A., SPROUSE, J., LIVANOS, E., JACKS, T. and TLSTY, T.D., Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70, 923-935 (1992).
18. LÜBBE, J., REICHEL, M., BURG, G. and KLEIHUES, P., Absence of p53 gene mutations in cutaneous melanoma. J. invest. Dermatol., 102, 819-821 (1994).
19. LUCA, M., LENZI, R., LEE-JACKSON, D., GUTMAN, M., FIDLER, I.J. and BAR-ELI, M., p53 mutations are infrequent and do not correlate with the metastatic potential of human melanoma cells. Int. J. Oncol., 3, 19-22 (1993).
20. MCGREGOR, J.M., YU, C.C.W., DUBLIN, E.A., BARNES, D.M., LEVISON, D.A. and MACDONALD, D.M., p53 immunoreactivity in human malignant melanoma and dysplastic naevi. Brit. J. Dermatol., 128, 606-611 (1993).
21. MONTANO, X., SHAMSER, M., WHITEHEAD, P., DAWSON, K. and NEWTON, J., Analysis of p53 in human cutaneous melanoma cell lines. Oncogene, 9, 1455-1459 (1994).
22. OHTA, M., NAGAI, H., SHIMIZU, M., RASIO, D., BERD, D., MASTRANGELO, M., SINGH, A.D., SHIELDS, J.A., SHIELDS, C.L., CROCE, C.M. and HUEBNER, K., Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitory gene, CDK4I, in melanoma. Cancer Res., 54, 5269-5272 (1994).
23. PIGNON, J.M., VINATIER, I., FANEN, P., JONVEAUX, P., TOURNILHAC, O., IMBERT, M., ROCHANT, H. and GOOSSENS, M., Exhaustive analysis of the p53 gene coding sequence by denaturing gradient gel electrophoresis: application to the detection of point mutations in acute leukemias. Human Mutat., 3, 126-132 (1994).
24. POLLOCK, P.M., YU, F., QIU, L., PARSONS, P.G. and HAYWARD, N.K., Evidence for u.v. induction of cdkn2 mutations in melanoma cell lines. Oncogene, 11, 663-668 (1995).
25. RO, Y.S., COOPER, P.N., LEE, J.A., QUINN, A.G., HARRISON, D., LANE, D., HORNE, C.H.W., REES, J.L. and ANGUS, B., p53 protein expression in benign and malignant skin tumours. Brit. J. Dermatol., 128, 237-241 (1993).
26. SOMMER, S.S., CUNNINGHAM, J., MCGOVERN, R.M., SAITOH, S., SCHROEDER, J.J., WOLD, L.E. and KOVACH, J.S., Pattern of p53 gene mutations in breast cancers of women of the Midwestern United States. J. nat. Cancer Inst., 84, 246-252 (1992).
27. SOUSSI, T., CARON DE FROMENTEL, C. and MAY, P., Structural aspects of the p53 protein in relation to gene evoluation. Oncogene, 5, 945-952 (1990).
28. SOUSSI, T., LEGROS, Y., LUBIN, R., ORY, K. and SCHLICHTHOLZ, B., Multifactorial analysis of p53 alteration in human cancer: a review. Int. J. Cancer, 57, 1-9 (1994).
29. STOFLET, E.S., KOEBERL, D.D., SARKAR, G. and SOMMER, S.S., Genomic amplification with transcript sequencing. Science, 239, 491-494 (1988).
30. STRETCH, J.R., GATTER, K.C., RALFKIAER, E., LANE, D.P. and HARRIS, A.L., Expression of mutant p53 in melanoma. Cancer Res., 51, 5976-5979 (1991).
31. VOLKENANDT, M., SCHLEGEL, U., NANUS, D.M. and ALBINO, A.P., Mutational analysis of the human p53 gene in malignant melanoma. Pigment Cell Res., 4, 34-40 (1991).
32. WEISS, J., SCHWECHHEIMER, K., CAVENEE, W.K., HERLYN, M. and ARDEN, K.C., Mutation and expression of the p53 gene in malignant melanoma cell lines. Int. J. Cancer, 54, 693-699 (1993).
33. YAMAMOTO, M. and TAKAHASHI, H., Immunohistochemical detection of the p53 oncoprotein in tumours of melanocytic origin. Virchows Arch. Pathol. Anat. Histopathol., 422, 127-132 (1993).
34. YIN, Y., TAINSKY, M.A., BISCHOFF, F.Z., STRONG, L.C. and WAHL, G.M., Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70, 937-948 (1992).